Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Breast Neoplasms 52Carcinoma, Renal Cell 47Neoplasm Metastasis 24Neoplasms 18Kidney Neoplasms 18Neuroendocrine Tumors 17Carcinoma, Non-Small-Cell Lung 13Tuberous Sclerosis 12Stomach Neoplasms 12Lymphoma, Mantle-Cell 12Lymphoma, Large B-Cell, Diffuse 11Recurrence 10Prostatic Neoplasms 10Lymphoma 10Hodgkin Disease 10Glioblastoma 10Colorectal Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Brain Neoplasms 9Lymphoma, Follicular 8Lung Neoplasms 8Leukemia, Lymphocytic, Chronic, B-Cell 8Carcinoma 8Waldenstrom Macroglobulinemia 7Triple Negative Breast Neoplasms 7Sarcoma 7Multiple Myeloma 7Lymphoma, B-Cell, Marginal Zone 7Glioma 7Central Nervous System Neoplasms 7

Interventions

midostaurin 2avapritinib 2Imatinib Mesylate 2sarilumab 1ripretinib 1nilotinib 1masitinib 1dexamethasone acetate 1dexamethasone 21-phosphate 1denileukin diftitox 1auricularum 1Thalidomide 1Ranitidine 1Interviews as Topic 1Ibuprofen 1Everolimus 1Diphenhydramine 1Dexamethasone 1Denosumab 1Calcium Dobesilate 1Brentuximab Vedotin 1Acetaminophen 1AK002 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mastocytosis, Systemic × Everolimus × Clear all
NCT00449748 2025-05-01

Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis

M.D. Anderson Cancer Center

Phase 2 Completed
10 enrolled 4 charts
Myeloid

Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡